India News

Opposition questions India gov’t on doubling vaccine dosing gap

A healthcare worker gives a dose of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, to a woman inside a classroom of a school, which has been converted into a temporary vaccination centre, in New Delhi, India, May 4, 2021. REUTERS/Adnan Abidi

NEW DELHI, June 16: – India’s main opposition party, Congress, on Wednesday questioned the decision by Prime Minister Narendra Modi’s government to double the gap between the doses of the AstraZeneca COVID-19 vaccine, asking whether it was prompted by a vaccine shortage.

Advertisements

IN PUBLIC INTEREST

*Cover your face with masks to prevent transmission of droplets carrying coronavirus
*Exercise social distancing
*Wash your hands frequently
*Sanitize your hands

STAY HOME & STAY SAFE!

 

On Tuesday, Reuters reported that the government had increased the gap without the agreement of the scientific group that it said recommended the move, citing three members of the National Technical Advisory Group on Immunisation (NTAGI) advisory body. read more

Congress leaders, including former party president Rahul Gandhi, said the government was trying to cover up a vaccine shortage.

“India needs quick & complete vaccination,” Gandhi said in a tweet.

The AstraZeneca shot accounts for nearly 90% of the 257.5 million vaccine doses administered in India, where some states have curtailed vaccination programmes over supply constraints.

The government said that the gap was increased based on scientific evidence and that the issue had been discussed in detail by members of NTAGI as well as its working group on COVID-19.

“We have a very open and transparent system where decisions are taken on scientific basis,” said N.K. Arora, chairman of the working group, according to a government statement on Wednesday.

Arora said that the decision to expand the gap to up to 16 weeks had been made to provide “flexibility” for those who may not be able to get the second dose at 12 weeks.

But NTAGI members told Reuters that the group had no data concerning the effects of a gap beyond 12 weeks, and Arora also did not cite such a study in Wednesday’s statement from the federal health ministry.

India’s health minister, Harsh Vardhan, said that India has a robust mechanism to evaluate data, reiterating that the decision to increase the gap was based on science.

“It’s unfortunate that such an important issue is being politicised!” he said in a tweet.Reporting by Devjyot Ghoshal; Editing by Sanjeev Miglani and Gerry Doyle

REUTERS

JUNE 16, 2021

Our Standards: The Thomson Reuters Trust Principles.

https://www.reuters.com/world/india/opposition-questions-india-govt-doubling-vaccine-dosing-gap-2021-06-16/

Leave a Reply